CRDF — Cardiff Oncology Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Cardiff Oncology Inc

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer. The company also focuses on the clinical program in indications, such as investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma, small… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$1.67
Market Cap$118M
Float66.7M
Shares Outstanding68.4M
Price/Sales (TTM)199.46
vs. Analyst Target+364.1% to analyst PT
Operating Margin (TTM)-3220.99%
Revenue (TTM)$593,000
Dividend RateNone
Analyst Target Price$7.75 (7 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $366,000 -$19.3M $366,000 -$18.8M
2021 $359,000 -$28.3M $359,000 -$28.4M
2022 $386,000 -$38.7M $386,000 -$39.7M
2023 $488,000 -$41.4M $488,000 -$45.0M
2024 $683,000 -$45.4M $683,000 -$48.2M
2025 $593,000 -$45.9M -$311,000 -$45.0M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Mar 2025 $109,000 -$13.4M
Jun 2025 $121,000 -$13.9M
Sep 2025 $120,000 -$11.3M
Dec 2025 $243,000 -$7.2M

Ownership & Float

Insider Ownership5.9%
Institutional Ownership34.9%
Short Float27.5%
% of All Funds Holding1.27%
Number of Funds Holding104

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$1.69Near-term / short-term trend
Weekly40-Week SMA$2.10Medium-term trend
Weekly80-Week SMA$2.78Cyclical trend (business cycle)
Weekly200-Week SMA$2.38Secular trend (multi-year)
Monthly10-Month SMA$2.03Near-term monthly trend
Monthly20-Month SMA$2.67Medium-term monthly trend
Monthly40-Month SMA$2.40Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$2.80 resistance 1.31x 3 months ago
$3.10 resistance 1.86x 9 months ago
$4.30 resistance 1.01x 13 months ago

Historical Earnings Reactions (56 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.52% 0.00% 48.21% 12.99% -20.00%
1 Day 0.52% 0.00% 39.29% 64.41% -25.71%
1 Week 3.70% -1.15% 39.29% 133.90% -34.29%
2 Weeks 5.25% -3.30% 42.86% 184.18% -34.29%
1 Month 5.06% -4.11% 40.00% 201.13% -74.11%

Next earnings: May 14, 2026

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan-4.1%36.4%22
Feb1.3%50.0%22
Mar2.4%31.8%22
Apr-3.3%36.4%22
May-1.8%33.3%21
Jun4.3%33.3%21
Jul7.6%33.3%21
Aug7.1%59.1%22
Sep-0.2%27.3%22
Oct-1.2%40.9%22
Nov4.5%40.9%22
Dec1.3%40.9%22

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.12% 33.4% 1027
Tuesday -0.10% 31.5% 1125
Wednesday 0.09% 34.8% 1126
Thursday 0.26% 34.3% 1104
Friday 0.27% 34.8% 1100

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 34.9%

Insider Transactions — Smart Summary

Total insider ownership: 5.9%

12-Month Insider Activity Summary

Total Filings1
Net Value+N/A
Net Shares Change290,000
% of Float0.4%
C-Suite Filings0
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
PACE GARY W +$710,500 1 2 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2025-07-31 PACE GARY W +$710,500 Transaction at $2.45, now -31.8%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Cardiff Oncology Inc (CRDF) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for CRDF on Trend Edge →